about
The role of nitric oxide in pre-synaptic plasticity and homeostasisMolecular mechanisms of neuronal nitric oxide synthase in cardiac function and pathophysiologyProtein kinase D interacts with neuronal nitric oxide synthase and phosphorylates the activatory residue serine 1412Targeting protein-protein interactions with trimeric ligands: high affinity inhibitors of the MAGUK protein familyProtein interacting with C-kinase 1 (PICK1) binding promiscuity relies on unconventional PSD-95/discs-large/ZO-1 homology (PDZ) binding modes for nonclass II PDZ ligands.Delineation of molecular pathway activities of the chronic antidepressant treatment response suggests important roles for glutamatergic and ubiquitin-proteasome systemsWhole-exome sequencing of individuals from an isolated population implicates rare risk variants in bipolar disorderNeuronal nitric oxide synthase (NOS1) polymorphisms interact with financial hardship to affect depression riskBacopa monnieri Extract (CDRI-08) Modulates the NMDA Receptor Subunits and nNOS-Apoptosis Axis in Cerebellum of Hepatic Encephalopathy RatsSource memory in rats is impaired by an NMDA receptor antagonist but not by PSD95-nNOS protein-protein interaction inhibitors.Pannexin1 as a novel cerebral target in pathogenesis of hepatic encephalopathy.Mechanisms of NOS1AP action on NMDA receptor-nNOS signaling.Neuronal nitric oxide synthase (NOS1) and its adaptor, NOS1AP, as a genetic risk factors for psychiatric disorders.Aquaporin-4 knockout exacerbates corticosterone-induced depression by inhibiting astrocyte function and hippocampal neurogenesis.Biochemical investigations of the mechanism of action of small molecules ZL006 and IC87201 as potential inhibitors of the nNOS-PDZ/PSD-95-PDZ interactions.Serine 707 of APPL1 is Critical for the Synaptic NMDA Receptor-Mediated Akt Phosphorylation Signaling PathwaySmall-molecule inhibitors at the PSD-95/nNOS interface have antidepressant-like properties in mice.Metaplastic effects of subanesthetic ketamine on CA1 hippocampal function.Regional Specific Modulation of Stress-Induced Neuronal Activation Associated with the PSD95/NOS Interaction Inhibitor ZL006 in the Wistar Kyoto Rat.Employment of Molecularly Imprinted Polymers to High-Throughput Screen nNOS-PSD-95 Interruptions: Structure and Dynamics Investigations on Monomer-Template Complexation.
P2860
Q26863770-40E190D4-5A23-4734-848F-C8A3B1CC6D17Q27023508-9495E0A5-21A9-40CD-A727-045B5F4D2FE9Q28537962-60653DB6-C601-4733-BA22-921C1FC38C9CQ28543254-69753BDC-4E9C-40C4-8C13-9228CE134055Q30364686-CF54A8AA-F403-480A-96B0-008E0A0BA418Q33635613-FB57B63B-A929-4AE6-80FC-5A9A730935DAQ33707718-7BD456F4-F359-4E2D-A128-BEBEC3D51D63Q34357009-43FED1E2-2E52-42D5-BB15-ECED90F1F5DBQ36043633-28790344-B0D3-4295-93C3-D523D6E68B10Q36730701-4674CE4D-699A-4660-98FE-F0721D65F582Q38210151-856F93F9-5451-4F7C-AAB3-B81C07B8C838Q38249173-C792E0DA-FD61-4D0B-A1C0-9C4A5302BD28Q38328635-AC6105D6-F47F-4321-A949-67E18F959A66Q39034588-2745C886-065C-41D3-9F81-4FDE2AB8207CQ40733593-CCB652B7-9028-44E4-A635-B0D3CE19EE85Q41465908-67B9C7DC-DCBA-4319-AE39-DF1D522AFED4Q41859954-FF1B09F8-8BC5-4C6D-BD40-AFCD9F3EA4E9Q41926184-045EE39C-10C7-4D32-B47A-55500391B69FQ42052984-957D5A9D-B1CF-4A04-ABA2-11EDDF59B991Q48067123-4D4EA5D2-097A-4ABD-AD73-6C91D23F8B35
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
The PSD-95/nNOS complex: new drugs for depression?
@en
The PSD-95/nNOS complex: new drugs for depression?
@nl
type
label
The PSD-95/nNOS complex: new drugs for depression?
@en
The PSD-95/nNOS complex: new drugs for depression?
@nl
prefLabel
The PSD-95/nNOS complex: new drugs for depression?
@en
The PSD-95/nNOS complex: new drugs for depression?
@nl
P1476
The PSD-95/nNOS complex: new drugs for depression?
@en
P2093
Marika V Doucet
P304
P356
10.1016/J.PHARMTHERA.2011.11.005
P577
2011-11-23T00:00:00Z